KBRA is pleased to announce the assignment of preliminary ratings to 28 classes of BANK5 2025-5YR18, a $709.9 million CMBS conduit transaction collateralized by 29 commercial mortgage loans secured by ...

Oramed Pharmaceuticals Inc. ORMP) on Thursday reported net income of $48.4 million in its third quarter. The New York-based company said it had profit of $1.13 per share.